Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is comparing Cariprazine with placebo for people with depression or Elderly. Participants receive Cariprazine or placebo and complete study visits and assessments.
This study is comparing Aticaprant with placebo for people with depression or Elderly. Participants receive Aticaprant or placebo and complete study visits and assessments.
This study is looking at whether Aticaprant can help people with depression or Elderly. Participants receive the study medicine Aticaprant and complete study visits and assessments.
This study is looking at care and outcomes for people with The aim of the study is to test augmentation of SSRI therapy with LY2422347 in who continue to manifest significant levels of depressive symptoms following an adequate treatment with an SS. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing Seltorexant with quetiapine for people with depression or Elderly. Participants receive Seltorexant or quetiapine and complete study visits and assessments.
This study is comparing VORTIOXETINE with Fluoxetine for people with depression or Children, Under 18. Participants receive VORTIOXETINE or Fluoxetine and complete study visits and assessments.
This study is comparing fremanezumab with placebo for people with Migraine and depression or Elderly. Participants receive fremanezumab or placebo and complete study visits and assessments.
This study is looking at whether ESKETAMINE Esketamine (for (S)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone) can help people with Treatment-resistant Major Depression or Elderly. Participants receive the study medicine ESKETAMINE Esketamine (for (S)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone) and complete study visits and assessments.
This study is trying to understand why some older adults do not talk about suicidal thoughts or ask for help during a crisis. Participants complete social thinking tasks, self-report measures, and mobile check-ins over time.
This study assessed the safety and pharmacology of SEP-380135 in adults living with schizophrenia or a major depressive episode linked to bipolarity or major depressive disorder. The registry now lists the study as completed.
This feasibility study is preparing to test whether people can tell if they received psilocybin or placebo when the treatment acts during sleep. The ISRCTN record lists the study as not yet recruiting.
This EU CTR study is testing sodium oxybate for catatonia in adults living with depression, bipolarity, or psychotic disorders. The registry page currently marks the Dutch protocol as transitioned, which the app maps to ongoing.
This EU CTR study explores how the microbiome may affect depression treatment and response. The public Dutch protocol is marked as transitioned, which the app maps to ongoing.
This study exists to see whether the medication COVID-19 can make care clearer and more responsive. Researchers are trying to understand whether the medication COVID-19 can give earlier or clearer feedback during care.
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
This study exists to understand how psychoeducation, a guided learning and support program, holds up over time after the earliest research stage. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve sleep, daily rhythms, and longer-term stability.
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.
This study exists to see whether the medication Inhibitory can play a useful role in care. Researchers are trying to understand whether the medication Inhibitory can improve attention, thinking, or day-to-day functioning.
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.
This study exists to see whether psychoeducation, a guided learning and support program, is workable and worth testing more broadly. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can make support easier to access outside standard clinic visits.
This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can work better when mental health difficulties overlap with substance use.